This estrogen-dependent property of 27HC on ERα activity qualifies it as the only characterized endogenously occurring selective estrogen receptor modulator (SERM) with a great potential to differentially impact ER+ BC progression and outcome depending on the patient menopausal status but this remains to be comprehensively investigated in clinical BC. Here, ESR1 is linked to breast cancer.